Posts

Showing posts with the label medicine

International Conference on Intelligent Biology and Medicine (ICIBM 2012)

DATES: April 22-24, 2012 LOCALE: Nashville, TN URL:   http://bioinfo.mc.vanderbilt. edu/icibm/index.html Bioinformatics, Systems Biology and Intelligent Computing are synergistic disciplines that hold great promise for the advancement of biomedical research and development through the design of intelligent systems to solve engineering practical problems as well as translational science problems. Research and development in these areas impact science and technology, and synergies among these disciplines provide enormous potential. The International Conference on Intelligent Biology and Medicine (ICIBM) aims to provide a forum for the cross- fertilization of ideas and promotion of interdisciplinary collaborations.

International Conference on Perspective of Cell Signaling and Molecular Medicine

2nd International Conference on  Perspective of Cell Signaling and Molecular Medicine   8 to 11 January, 2012  Organised by  Bose Institute, Kolkata Instructions for Submission of Abstract : 1. Only abstracts containing new results will be accepted. Abstracts should clearly and adequately describe the objectives and results of the research. All abstracts must be submitted in English. All abstracts must be accompanied by a completed Conference Registration Form made out in the name of one of the Authors. a. Each abstract should include a title (in capital letters), name(s) of all authors (underline the presenting author), affiliation and email address. b. Type entire abstract single-spaced; typing area: width 12.0 cm (4.7 inches), height 24 cm (9.4 inches). c. Careful typing and proof-reading are essential. Registration : Registration fees : Rs. 4,000/ (Scientist); Rs. 2,500/ (Students including post-docs) Late Registration fees : Rs. 5,000/ and Rs. 3,500/ r...

Robert Geoffrey Edwards, for developing in vitro fertilization (IVF) in humans, receives this year's Nobel Prize for Physiology or Medicine

Image
Robert Geoffrey Edwards, who developed in vitro fertilization (IVF) in humans, will receive this year's  Nobel Prize for Physiology or Medicine. Human oocyte Image:wikimedia commons/Ekem The initially controversial technology has since produced more than 4 million babies worldwide to otherwise infertile parents. When Edwards, now professor emeritus at the University of Cambridge, started his research on infertility in the 1950s, scientists had already successfully fertilized eggs from rabbits in test tubes and produced young. It didn't take much time for Edwards to realize that fertilization outside of the uterus could be a viable option for human couples who were having issues conceiving. While on the road to developing IVF, Edwards made myriad discoveries that have contributed to researchers' understanding of the maturation of the human egg cell. For example, he deciphered how different hormones control the development of the egg, as well as when the egg is most ...

Conference on Semantics in Healthcare and Life Sciences (CSHALS)

C SHALS is the premier annual event focused on the use of semantic technologies in the pharmaceutical industry, including hospitals/healthcare institutions and academic research labs. Rather than a Semantic Web conference, CSHALS focuses on specific applications of semantic technologies. Attendees will gain a better understanding of where the field is headed and be prepared to advance with the field. Themes of past CSHALS conferences: Clinical Information Management Discovery Information Integration Integrated Healthcare and Semantics in Electronic Health Records Translational Medicine / Safety Search and Document Management/Business Intelligence/Text Mining Text Mining/ Information Extraction For further details visit   Share |

Mayo Clinic, Microsoft Team on Patient Health Record Plus

Mayo Clinic is extending its brand across the country. This time, it is offering a free personal health record on the Microsoft HealthVault platform. The Mayo Clinical Health Manager , as the PHR is known, will provide not only a secure place to store medical records online, but also guidance from Mayo experts that will be tailored to the information contained in that PHR. If you are a 50-year-old man with diabetes and hypertension, for example, you will receive information about how you should take care of those conditions and the tests you should receive. Initially, Mayo Clinic Health Manager will include tools and features that help consumers manage pediatric and adult wellness, immunizations, pregnancy and asthma. Forthcoming features will help users with type 2 diabetes, high cholesterol, and/or high blood pressure. According to Mayo’s press kit , PHR users will be able to “transfer data directly into [a] Mayo Clinic Health Manager profile from a wide range of providers, devices...

Regenerative Medicine Start-Up Created out of ORNL

Battelle Ventures has spun out a firm from the U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL), with an initial $1.5 million seed investment. The company, called NellOne Therapeutics, will develop regenerative medicines. The funding will be tranched based on key technical milestones. Towards a "holy grail" in human medicine: the ability to restore organs damaged through trauma, disease, cancer, or even the normal aging process. Tissue or organ repair has been the ultimate goal of surgery from ancient times to the present day. Clearly, there is a lot of interest in the regeneration of tissues, and tissue repair in organisms is within reach. However, we are a long way from understanding how to coax the human body into regenerating complex body parts after injury or disease. As an example, regeneration of amputated limbs in amphibians - “epimorphic” regeneration which includes cellular dedifferentiation in the injured tissues of the limb stump and proliferat...

Pfizer invests $300 mln in Irish biotech facility

Pfizer Inc, the world's biggest drugmaker, is to invest 190 million euros ($297 million) establishing a new biotech plant in Ireland for the production of experimental medicines, it said on Friday. It is the first time that Pfizer has placed such internal biopharmaceutical clinical development outside the United States. The facility at Shanbally in County Cork will be located on a site adjacent to Pfizer's existing operation in Ringaskiddy and will be completed by the end of 2009. Nat Ricciardi of Pfizer Global Manufacturing said the investment reflected the U.S. group's determination to become a leader in biotech medicine, which is a growing focus for many drug companies worldwide.